The First Global Generic Afatinib Afanix:Afatinib is a targeted therapy. Afatinib is classified as a Tyrosine Kinase inhibitor; Epidermal Growth Factor Receptor (EGFR) inhibitor.Therapeutic IndicationsEGFR Mutation-Positive, Metastatic Non-Small Cell Lung CancerAfatinib is indicated for the first-line treatment of patients with metastatic non-small
Category: Health
Country: Bangladesh (BD)
Platform: Custom Cart
Technologies used: Google Adsense, Google Analytics, Google Tag Manager, Yoast
Contact page: https://www.afanix.com/contact
Signup for Free. No Credit Card required.Suitable for marketing agencies, app developers and new business ideas.
No credit card required.